Blyth W A, Harbour D A, Hill T J
Infect Immun. 1980 Sep;29(3):902-7. doi: 10.1128/iai.29.3.902-907.1980.
Mice latently infected with herpes simplex virus were treated with immunosuppressive drugs either alone or combined with stimuli to the skin. Treatment with cyclophosphamide reduced spleen weights and severely depressed lymphocyte levels, but had no effect on healing after cellophane tape stripping (CTS) and did not affect the cutaneous hypersensitivity response after injection of inactivated herpes simplex virus. The drug, either used alone or combined with CTS, failed to increase the incidence of recurrent clinical disease, but increased the incidence of virus isolation after CTS. Prednisolone and azathioprine used together also reduced spleen weights and circulating lymphocyte levels. They slightly delayed healing after CTS, but had no effect on cutaneous hypersensitivity to herpes simplex virus. The treatment, either used alone or combined with CTS, slightly increased the incidence of recurrent clinical disease but did not increase the incidence of virus isolation after CTS. Treatment with antithymocyte serum severely depressed the levels of circulating lymphocytes and delayed the regression of HeLa cell tumors in mice. Used alone, the treatment slightly increased the incidence of recurrent clinical disease, but it failed to increase the incidence of recurrences after CTS. It increased the duration of recurrent herpetic lesions, although in uninfected mice healing after CTS was not affected. Silica altered the clinical course of primary infection with herpes simplex virus and increased the incidence of latency in the ganglia. It also delayed healing after CTS in uninfected mice, so it was not tested when recurrent herpes after CTS was assessed clinically. Treatment with silica alone did not increase the incidence of recurrent clinical disease or the incidence of virus isolation after CTS. The results demonstrate that potent immunosuppressive drugs are much less effective than simple cutaneous manipulation in inducing recurrent lesions, and thus argue strongly for the importance of local factors in the pathogenesis of disease.
对潜伏感染单纯疱疹病毒的小鼠单独或联合皮肤刺激使用免疫抑制药物进行治疗。环磷酰胺治疗可降低脾脏重量并严重降低淋巴细胞水平,但对透明胶带剥离(CTS)后的愈合没有影响,且不影响注射灭活单纯疱疹病毒后的皮肤超敏反应。该药物单独使用或与CTS联合使用,均未能增加复发性临床疾病的发生率,但增加了CTS后病毒分离的发生率。泼尼松龙和硫唑嘌呤联合使用也会降低脾脏重量和循环淋巴细胞水平。它们使CTS后的愈合稍有延迟,但对单纯疱疹病毒的皮肤超敏反应没有影响。该治疗单独使用或与CTS联合使用,会使复发性临床疾病的发生率稍有增加,但不会增加CTS后病毒分离的发生率。抗胸腺细胞血清治疗可严重降低循环淋巴细胞水平,并延迟小鼠HeLa细胞瘤的消退。单独使用该治疗,会使复发性临床疾病的发生率稍有增加,但未能增加CTS后的复发率。它增加了复发性疱疹性病变的持续时间,尽管在未感染的小鼠中CTS后的愈合不受影响。二氧化硅改变了单纯疱疹病毒原发性感染的临床病程,并增加了神经节潜伏的发生率。它还延迟了未感染小鼠CTS后的愈合,因此在临床评估CTS后的复发性疱疹时未对其进行测试。单独使用二氧化硅治疗不会增加复发性临床疾病的发生率或CTS后病毒分离的发生率。结果表明,强效免疫抑制药物在诱导复发性病变方面比简单的皮肤操作效果要差得多,因此有力地证明了局部因素在疾病发病机制中的重要性。